National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting, 89020-89021 [2024-26073]

Download as PDF 89020 Federal Register / Vol. 89, No. 218 / Tuesday, November 12, 2024 / Notices other than their time. The total estimated annualized burden hours are 2,000. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondent Average time per response (in hours) Total annual burden hour Individuals (standard DUC form) ..................................................................... Individuals (additional AI/AN DUC form when needed) .................................. 1,800 200 1 1 1 1 1,800 200 Total .......................................................................................................... ...................... 2,000 ........................ 2,000 Lanette A. Palmquist, Project Clearance Liaison, National Institute on Drug Abuse, National Institutes of Health. [FR Doc. 2024–26138 Filed 11–8–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Fogarty International Center; Notice of Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Fogarty International Center Advisory Board. This will be a hybrid meeting held inperson and virtually and will be open to the public as indicated below. Individuals who plan to attend inperson or view the virtual meeting and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The open session can be accessed from the Fogarty International Center website (https://www.fic.nih.gov/About/ Advisory/Pages/default.aspx). The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. khammond on DSKJM1Z7X2PROD with NOTICES Number of responses per respondent Name of Committee: Fogarty International Center Advisory Board. Date: February 10–11, 2025. Closed: February 10, 2025, 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate the second level of grant applications. Address: Fogarty International Center, National Institutes of Health, Lawton Chiles VerDate Sep<11>2014 16:35 Nov 08, 2024 Jkt 265001 International House (Stone House), 16 Center Drive, Conference Room, Bethesda, MD 20892 (In-person and Virtual Meeting). Open: February 11, 2025, 9:00 a.m. to 3:00 p.m. Agenda: Update and discussion of current and planned Fogarty International Center activities. Address: Fogarty International Center, National Institutes of Health, Lawton Chiles International House (Stone House), 16 Center Drive, Conference Room, Bethesda, MD 20892 (In-person and Virtual Meeting). Meeting Access: https://www.fic.nih.gov/ About/Advisory/Pages/default.aspx. Contact Person: Kristen Weymouth, Executive Secretary, Fogarty International Center, 31 Center Drive, Room B2C02, Bethesda, MD 20892, 301–495–1415, kristen.weymouth@nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Persons listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has procedures at https://www.nih.gov/ about-nih/visitor-information/ campusaccess-security for entrance into on-campus and off-campus facilities. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors attending a meeting on campus or at an off-campus federal facility will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// www.fic.nih.gov/About/Advisory/Pages/ default.aspx, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.106, Minority International Research Training Grant in the Biomedical and Behavioral Sciences; 93.154, Special International Postdoctoral Research Program in Acquired Immunodeficiency Syndrome; 93.168, International Cooperative Biodiversity Groups Program; 93.934, Fogarty PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 International Research Collaboration Award; 93.989, Senior International Fellowship Awards Program, National Institutes of Health, HHS) Dated: November 5, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–26112 Filed 11–8–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Diabetes and Digestive and Kidney Diseases Advisory Council. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Diabetes and Digestive and Kidney Diseases Advisory Council. Date: January 29–30, 2025. Open: January 29, 2025, 8:30 a.m. to 12:00 p.m. E:\FR\FM\12NON1.SGM 12NON1 khammond on DSKJM1Z7X2PROD with NOTICES Federal Register / Vol. 89, No. 218 / Tuesday, November 12, 2024 / Notices Agenda: Call to order; Announcements; Consideration of Summary Minutes for May 2024 Council, Future Council Dates; Report from the Director; Speakers; Concept Clearance. Address: National Institutes of Health, Building 31, C Wing 6th Floor Conference Room, 31 Center Drive, Bethesda, MD 20892 (In-Person and Virtual Meeting). Open: January 29, 2025, 1:00 p.m. to 2:30 p.m. Agenda: KUH Open session. Address: National Institutes of Health, Building 31, C Wing 6th Floor Conf. Room B (KUH), 31 Center Drive, Bethesda, MD 20892 (In-Person and Virtual Meeting). Open: January 29, 2025, 1:00 p.m. to 2:15 p.m. Agenda: DEM Open session. Address: National Institutes of Health, Building 31, C Wing 6th Floor Conf. Room F&G (DEM), 31 Center Drive, Bethesda, MD 20892 (In-Person and Virtual Meeting). Open: January 29, 2025, 1:00 p.m. to 2:30 p.m. Agenda: DDN Open session. Address: National Institutes of Health, Building 31, C Wing 6th Floor Conf. Room A (DDN), 31 Center Drive, Bethesda, MD 20892 (In-Person and Virtual Meeting). Closed: January 29, 2025, 2:15 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Building 31, C Wing 6th Floor Conf. Room A (DDN), 31 Center Drive, Bethesda, MD 20892 (In-Person and Virtual Meeting). Closed: January 29, 2025, 2:15 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Building 31, C Wing 6th Floor Conf. Room B (KUH), 31 Center Drive, Bethesda, MD 20892 (In-Person and Virtual Meeting). Closed: January 29, 2025, 2:15 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Building 31, C Wing 6th Floor Conf. Room F&G (DEM), 31 Center Drive, Bethesda, MD 20892 (In-Person and Virtual Meeting). Closed: January 29, 2025, 3:45 p.m. to 4:00 p.m. Agenda: Reports of Subcommittees and Consideration of Applications. Address: National Institutes of Health, Building 31, C Wing 6th Floor Conf. Room F&G, 31 Center Drive, Bethesda, MD 20892 (In-Person and Virtual Meeting). Contact Person: Karl F. Malik, Ph.D., Director Division of Extramural Activities, National Institutes of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd., Room 7329, MSC 5452, Bethesda, MD 20892, (301) 594–4757, malikk@niddk.nih.gov. Information is also available on the Institute’s/Center’s home page: VerDate Sep<11>2014 16:35 Nov 08, 2024 Jkt 265001 www.niddk.nih.gov/fund/divisions/DEA/ Council/coundesc.htm., where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: November 5, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–26073 Filed 11–8–24; 8:45 am] BILLING CODE 4140–01–P National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; NIDDK RC2 Review. Date: December 11, 2024. Time: 11:00 a.m. to 12:30 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, NIDDK, Democracy II, Suite 7000A, 6707 Democracy Boulevard, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Thomas A. Tatham, Ph.D., Scientific Review Officer, National Institute of Diabetes and Digestive and Kidney, National Institute of Health, 6707 Democracy Boulevard, Rm. 7021, Bethesda, MD 20892– 5452, (301) 594–3993, tathamt@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Frm 00072 Fmt 4703 Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: November 5, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–26071 Filed 11–8–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Closed Meeting DEPARTMENT OF HEALTH AND HUMAN SERVICES PO 00000 89021 Sfmt 4703 Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Special Emphasis Panel; NIMH HIV/AIDS Review (P30, R25, T32, K99). Date: December 11, 2024. Time: 11:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. Meeting Format: Virtual Meeting. Contact Person: Rebecca Steiner Garcia, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, National Institutes of Health, 6001 Executive Blvd, Bethesda, MD 20892, 301–443–4525, email: steinerr@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.242, Mental Health Research Grants, National Institutes of Health, HHS) Dated: November 6, 2024. Bruce A. George, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–26139 Filed 11–8–24; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\12NON1.SGM 12NON1

Agencies

[Federal Register Volume 89, Number 218 (Tuesday, November 12, 2024)]
[Notices]
[Pages 89020-89021]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-26073]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Diabetes 
and Digestive and Kidney Diseases Advisory Council.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Diabetes and Digestive and Kidney 
Diseases Advisory Council.
    Date: January 29-30, 2025.
    Open: January 29, 2025, 8:30 a.m. to 12:00 p.m.

[[Page 89021]]

    Agenda: Call to order; Announcements; Consideration of Summary 
Minutes for May 2024 Council, Future Council Dates; Report from the 
Director; Speakers; Concept Clearance.
    Address: National Institutes of Health, Building 31, C Wing 6th 
Floor Conference Room, 31 Center Drive, Bethesda, MD 20892 (In-
Person and Virtual Meeting).
    Open: January 29, 2025, 1:00 p.m. to 2:30 p.m.
    Agenda: KUH Open session.
    Address: National Institutes of Health, Building 31, C Wing 6th 
Floor Conf. Room B (KUH), 31 Center Drive, Bethesda, MD 20892 (In-
Person and Virtual Meeting).
    Open: January 29, 2025, 1:00 p.m. to 2:15 p.m.
    Agenda: DEM Open session.
    Address: National Institutes of Health, Building 31, C Wing 6th 
Floor Conf. Room F&G (DEM), 31 Center Drive, Bethesda, MD 20892 (In-
Person and Virtual Meeting).
    Open: January 29, 2025, 1:00 p.m. to 2:30 p.m.
    Agenda: DDN Open session.
    Address: National Institutes of Health, Building 31, C Wing 6th 
Floor Conf. Room A (DDN), 31 Center Drive, Bethesda, MD 20892 (In-
Person and Virtual Meeting).
    Closed: January 29, 2025, 2:15 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Building 31, C Wing 6th 
Floor Conf. Room A (DDN), 31 Center Drive, Bethesda, MD 20892 (In-
Person and Virtual Meeting).
    Closed: January 29, 2025, 2:15 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Building 31, C Wing 6th 
Floor Conf. Room B (KUH), 31 Center Drive, Bethesda, MD 20892 (In-
Person and Virtual Meeting).
    Closed: January 29, 2025, 2:15 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Building 31, C Wing 6th 
Floor Conf. Room F&G (DEM), 31 Center Drive, Bethesda, MD 20892 (In-
Person and Virtual Meeting).
    Closed: January 29, 2025, 3:45 p.m. to 4:00 p.m.
    Agenda: Reports of Subcommittees and Consideration of 
Applications.
    Address: National Institutes of Health, Building 31, C Wing 6th 
Floor Conf. Room F&G, 31 Center Drive, Bethesda, MD 20892 (In-Person 
and Virtual Meeting).
    Contact Person: Karl F. Malik, Ph.D., Director Division of 
Extramural Activities, National Institutes of Diabetes and Digestive 
and Kidney Diseases, 6707 Democracy Blvd., Room 7329, MSC 5452, 
Bethesda, MD 20892, (301) 594-4757, [email protected].
    Information is also available on the Institute's/Center's home 
page: www.niddk.nih.gov/fund/divisions/DEA/Council/coundesc.htm., 
where an agenda and any additional information for the meeting will 
be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: November 5, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-26073 Filed 11-8-24; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.